Not applicableUnknownNCT02280265What this trial is testingEfficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia AWho this might be right forHemophilia A Nanjing Medical University 15
Testing effectiveness (Phase 2)Study completedNCT02394730What this trial is testingAttenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation EndpointsWho this might be right forHIV Kirby Institute 65
Large-scale testing (Phase 3)Study completedNCT00168077What this trial is testingProthrombin Complex Concentrate for Anticoagulant ReversalWho this might be right forAcquired Coagulation Factor Deficiency CSL Behring 40
Not applicableStudy completedNCT03304977What this trial is testingPatient's Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph's Hospital)Who this might be right forCoagulation Disorder Fondation Hôpital Saint-Joseph 100
Post-approval studies (Phase 4)UnknownNCT05391412What this trial is testingEffect of Prophylactic Fibrinogen Concentrate In Scoliosis SurgeryWho this might be right forFibrinogenSpine DeformityCoagulopathy, Consumption+1 more Brno University Hospital 32
Not applicableUnknownNCT02503267What this trial is testing"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"Who this might be right forCongenital Heart DiseasesConotruncal DefectsCongenital Disorder of Glycosylation+1 more Hospital Universitari Vall d'Hebron Research Institute 300
Post-approval studies (Phase 4)Study completedNCT05326139What this trial is testingTopical Tranexamic Acid Application in RhinoplastyWho this might be right forEcchymosis; EyelidEdemaRhinoplasty Baskent University 50
Large-scale testing (Phase 3)Study completedNCT05422365What this trial is testingIntravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in AdultsWho this might be right forPrimary Immune Thrombocytopenia Biopharma Plasma LLC 32
Not applicableStudy completedNCT01862367What this trial is testingUse of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational StudyWho this might be right forCongenital Bleeding DisorderCongenital FXIII Deficiency Novo Nordisk A/S 30
Post-approval studies (Phase 4)Study completedNCT05237492What this trial is testingThe Influence of Tramadol on Platelet FunctionWho this might be right forDrug ToxicityPlatelet DysfunctionClotting Disorder Medical University of Graz 33
Not applicableLooking for participantsNCT04398628What this trial is testingATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersWho this might be right forHematologic DisorderBleeding DisorderConnective Tissue Disorder+10 more American Thrombosis and Hemostasis Network 3,000
Not applicableNot Yet RecruitingNCT07349134What this trial is testingWELL-MPN: A Digital Lifestyle App for Patients With MPNsWho this might be right forMyeloproliferative Neoplasms (MPNs) Brigham and Women's Hospital 75
Not applicableLooking for participantsNCT07230067What this trial is testingSepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）Who this might be right forSepsisSepsis and Coagulopathy Nanfang Hospital, Southern Medical University 1,500
Post-approval studies (Phase 4)Study completedNCT01558739What this trial is testingExploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)Who this might be right forPrimary Myelofibrosis (PMF)Post Polycythaemia Myelofibrosis (PPV MF)Post Essential Thrombocythaemia Myelofibrosis (PET-MF) Novartis Pharmaceuticals 48
Not applicableNot Yet RecruitingNCT06994312What this trial is testingThe Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing HemofiltrationWho this might be right forSepsis-induced Coagulopathy (SIC) The First Hospital of Jilin University 282
Not applicableUnknownNCT05523128What this trial is testingThe Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.Who this might be right forHemophilia A Institute of Hematology & Blood Diseases Hospital, China 6
Not applicableStudy completedNCT04121767What this trial is testingSafety and Efficacy of Edoxaban in Thoracoscopic AblationWho this might be right forAtrial FibrillationAnticoagulants and Bleeding Disorders Samsung Medical Center 60
Early research (Phase 1)Study completedNCT03603132What this trial is testingEvaluate Different Intervals Between Dosing and Feeding on the PharmacokineticsWho this might be right forImmune Thrombocytopenia Jiangsu HengRui Medicine Co., Ltd. 15
Early research (Phase 1)Looking for participantsNCT05500807What this trial is testingEmicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia AWho this might be right forVon Willebrand Disease, Type 3Concomitant VWD and Hemophilia Bleeding and Clotting Disorders Institute Peoria, Illinois 40
Large-scale testing (Phase 3)Study completedNCT02053792What this trial is testingA Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia BWho this might be right forHemophilia B CSL Behring 97